Ipamorelin
Also known as: Ipamorelin Acetate, NNC 26-0161
Ipamorelin is a pentapeptide growth hormone secretagogue that acts on the ghrelin receptor (GHS-R1a) in the pituitary gland to stimulate growth hormone release. Unlike other GH secretagogues such as GHRP-6, ipamorelin is highly selective and does not cause significant increases in cortisol, prolactin, or appetite, making it one of the cleanest GH-stimulating peptides available. It produces a dose-dependent GH release pattern that closely mimics natural pulsatile secretion. Ipamorelin is frequently combined with CJC-1295 for synergistic effects on GH output.
Growing body of research
Well-tolerated with minimal side effects
How It Works
Ipamorelin is a selective GH secretagogue that binds to ghrelin receptors on pituitary cells, stimulating GH release without affecting cortisol, prolactin, or ACTH.
Key Benefits
- Selective growth hormone release without cortisol spikes
- Improved recovery from exercise and injury
- Enhanced fat metabolism and body composition
- Better sleep quality
- Supports collagen synthesis and joint health
- Minimal impact on appetite compared to other GH secretagogues
Who May Benefit
- Adults seeking GH optimization with minimal side effects
- Individuals improving body composition and recovery
- People wanting GH benefits without cortisol elevation
- Those combining with CJC-1295
Dosage & Administration
Expected Timeline
Sleep and recovery improvements in 2-3 weeks. Body composition changes at 6-8 weeks.
Safety Information
Possible Side Effects
Contraindications
Dr. Taylor's 2 Cents
“What sets ipamorelin apart is its selectivity and half-life — it stimulates GH release without spiking cortisol or prolactin, which is a problem with older secretagogues like GHRP-6. I combine it with CJC-1295 in most of my GH optimization protocols. Patients love it because it improves sleep almost immediately, and the body composition changes follow within weeks.”
Discuss with Dr. Taylor →Frequently Asked Questions
What makes Ipamorelin different?
Is it combined with other peptides?
What dosage is typical?
Does Ipamorelin cause hunger?
How long can I take it?
Published Research
Ipamorelin, the First Selective Growth Hormone Secretagogue
Raun K, Hansen BS, Johansen NL, et al. · European Journal of Endocrinology (1998)
Key Finding: Ipamorelin displayed high GH-releasing potency and did not increase ACTH or cortisol even at doses 200-fold above the ED50 for GH release, making it the first truly selective GH secretagogue.
Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers
Gobburu JVS, Agersø H, Jusko WJ, Ynddal L · Pharmaceutical Research (1999)
Key Finding: Ipamorelin induced dose-proportional GH release at all dose levels in healthy male volunteers with predictable pharmacokinetics and reliable GH stimulation.
Protocols Featuring Ipamorelin
Related Reading
Want personalized guidance?
Consult with Dr. Patrick Taylor for a comprehensive evaluation and personalized protocol.
Book a ConsultationMedical Disclaimer: This information is for educational purposes only and is not medical advice. Consult a healthcare provider before starting any peptide protocol.